Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD
For female patients aged at least 66 years, odds of prevalent CVD up with locally advanced and metastatic disease
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
Approval based on noninferior pharmacokinetic exposures, similar effectiveness and safety to intravenous Opdivo
Patient-Centered Pathology Reports Improve Prostate Cancer Understanding
Benefits include better discrimination between risk levels
More Than Half of People With Rheumatoid Arthritis Have Anemia
Anemia significantly associated with higher disease severity, elevated inflammatory markers
Prebiopsy MRI Oncologically Safe for Suspected Prostate Cancer
Men with negative mpMRI results avoiding biopsy did not have increased risk for clinically significant prostate cancer
Platinum Chemo Shortage Led to Reduced Use, No Change in Mortality
Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage
Proposed FDA Rule Targets Asbestos in Talc Cosmetic Products
Age Impacts Surgical Outcomes for Breast Reconstruction
Significant association seen for older age with increased risk for developing mastectomy skin flap/nipple necrosis, infection, seroma
U.S. Health Care Spending Reached $4.9 Trillion in 2023
Health sector's share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
Ryoncil is first FDA-approved mesenchymal stromal cell therapy for pediatric patients aged 2 months or older
